Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Actonel Satisfaction and Compliance in Postmenopausal Osteoporosis
NCT00453492Phase 4Completed
- Sponsor
- Sanofi
- Start
- Jan 2004
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of risedronate in postmenopausal osteoporosis, sponsored by Sanofi. Started Jan 2004; status: completed.
02
Drugs
risedronate
03
Conditions
postmenopausal osteoporosis
Beyond the preview
Go deeper on NCT00453492.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00453492.